Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Publication | Closed Access

DOI

866

Citations

References

2016

Year

Sally E. Wenzel, Mario Castro, Jonathan Corren, Jorge Máspero, Lin Wang, Bingzhi Zhang, Gianluca Pirozzi, E. Rand Sutherland, Robert R. Evans, Vijay N. Joish,

The Lancet

AsthmaPulmonary CareAllergyClinical TrialsDupilumab EfficacyPulmonary PharmacologyDose-ranging TrialPulmonary MedicinePharmacotherapyLong-acting β2 AgonistPharmacologic InterventionMedicinePulmonary Disease